Hubly Surgical

Executive Summary

Hubly Surgical is a medical device company headquartered in San Francisco, California, focused on modernizing bedside intracranial access. Founded in 2019, the company has developed the Hubly Drill, an FDA-cleared, single-use cranial access kit and drill designed to improve safety and efficiency for common neurosurgical procedures such as burr hole drilling. The product addresses a critical need in neurosurgery by reducing the risk of complications associated with traditional drilling methods, and its single-use design eliminates the need for sterilization, streamlining workflow in both hospital and emergency settings. Hubly Surgical's mission is to enhance surgical safety and patient outcomes across all care settings, starting with neurosurgery. The global cranial access market is growing, driven by an aging population and increasing prevalence of neurological conditions. Hubly's differentiated product has the potential to capture market share by offering a standardized, safer, and more efficient alternative to reusable drills. With FDA clearance already secured, the company is well-positioned for commercial launch and expansion into surgical centers and hospitals. However, as a private company with limited financial data, execution risks remain. Overall, Hubly Surgical presents a compelling opportunity in the niche of neurosurgical access devices, with a validated product and clear unmet need.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance expansion for additional indications (e.g., emergency burr hole)40% success
• Q4 2026Commercial launch and first hospital sales milestone60% success
• TBDStrategic partnership or distribution agreement with a larger medtech company30% success